A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: prejudice (13)

NilotinibAccelerated

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (accelerated phase) Regimen • CML – Nilotinib (accelerated phase) Indication • Nilotinib is an option
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibAccelerated.pdf

NilotinibChronic

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (chronic phase) Regimen • CML – Nilotinib (chronic phase) Indication • As an option for the treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibChronic.pdf

IPD-Dexamethasone-Isatuximab-Pomalidomide

Description
Chemotherapy Protocol Myeloma Isatuximab-Dexamethasone (40)-Pomalidomide Regimen • Myeloma – Isatuximab-Dexamethasone (40)-Pomalidomide Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/IPD-Dexamethasone-Isatuximab-Pomalidomide.pdf

Ipilimumab(1mg/kg)-Nivolumab(3mg/kg)

Description
Chemotherapy Protocol RENAL CANCER IPILIMUMAB (1mg/kg)-NIVOLUMAB(3mg/kg) Regimen • Renal – Ipilimumab (1mg/kg)-Nivo
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Ipilimumab1mgkg-Nivolumab3mgkg.pdf

Dabrafenib Ver 1

Description
Chemotherapy Protocol SKIN CANCER DABRAFENIB Regimen Skin – Dabrafenib Indication Dabrafenib is recommended as an option for t
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDabrafenibVer1.pdf

Asciminib

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Asciminib Regimen • Asciminib Indication • Patients with chronic phase Philadelphia chromos
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Asciminib.pdf

Regorafenib

Description
Chemotherapy Protocol Gastro-Intestinal Stromal Tumour Regorafenib Regimen • GIST – Regorafenib Indication • Regorafenib is recommended for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Regorafenib.pdf

DasatinibChronic

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (chronic phase) Funding may be required for specific indications Regimen • CML – Dasatinib (chr
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibChronic.pdf

Ruxolitinib

Description
Chemotherapy Protocol Myelofibrosis Ruxolitinib Regimen • Myelofibrosis – Ruxolitinib Indication • Ruxolitinib is recommended as an option for treating d
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myelofibrosis/Ruxolitinib.pdf

Selinexor Bortezomib Dexamethasone

Description
Chemotherapy Protocol Multiple Myeloma Selinexor with Bortezomib and Dexamethasone Regimen • SELINEXOR (PO) – BORTEZOMIB (SC) – DEXAMETHASONE (PO) Indication Selinexor plus bortezomib and dexamethaso
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Selinexor-Bortezomib-Dexamethasone-Ver1.pdf
1 to 10 of 156
Previous 1 2 3 4 5 … Next